Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
Clinical trial NCT04644575 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04644575
- Sponsor
- Bioverativ, a Sanofi company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2027-01-15
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.